Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Neoplasie
15. Mai 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 7981
Artikel 1 - 20 / 159615
Margin Quality Analysis and Risk Factors Associated With Insufficient Margins Following Segmentectomy for Small-Sized Non-Small Cell Lung Cancer.
Thorac Cancer
Zhao C, Liu K, Li Z, Xu W, Wu Y, Chen L.
PMID: 42137988 [PubMed - indexed for MEDLINE]
Association between planetary health diet index and lung cancer risk in 106,542 participants: a prospective cohort study.
Front Nutr
Zhu J, Gu H, Zeng Z, Xiao Y, Shi Y, Me Z, Peng L, Xiang L, Luo Y, Chen Y, Jiang X.
PMID: 42137860 [PubMed]
Heated Tobacco Products: Current Evidence of Pulmonary Harm and Lung Cancer Risk.
Cureus
Albuquerque BL, Coelho IM, Albuquerque IL, Lanhas H, Vilaça AF.
PMID: 42137672 [PubMed]
Histone deacetylase-based dual inhibitors: research progress focusing on non-small cell lung cancer therapy.
RSC Med Chem
Liu Z, Yang Z.
PMID: 42137438 [PubMed - as supplied by publisher]
Ebracteolata cpd B causes ferroptosis and inhibits progression of lung adenocarcinoma.
Front Pharmacol
Du Y, Han H, Dong Y, Yin X, Zhu J, Yin C, Wang H.
PMID: 42137330 [PubMed]
Non-invasive prediction of prognostic immune subtypes in lung adenocarcinoma using PET/CT-based radiomics.
Front Oncol
Zhang S, Wang Y, Dai D, Xu W.
PMID: 42137172 [PubMed]
Cardiometabolic comorbidities and prostate cancer risk: evidence from the prostate, lung, colorectal, and ovarian cancer screening trial.
Front Oncol
Zhu Q, Zeng L, Chen M.
PMID: 42137169 [PubMed]
Incidence and Prognostic Value of TP53, STK11, and KEAP1 Mutations Between De Novo Versus Recurrent Actionable Mutation-Negative Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.
World J Oncol
Vazquez-Urrutia JR, Venugopal N, Zhu J, Komiya T.
PMID: 42136763 [PubMed]
The therapeutic value of antidiabetic drugs in lung cancer treatment: from clinical evidence to possible mechanisms.
Front Immunol
Wang Q, Xu J, Liu Q, Zhou H, Hu Y.
PMID: 42136675 [PubMed - indexed for MEDLINE]
Role of thoracic radiotherapy for extensive-stage small cell lung cancer in the era of immunotherapy: a review of current evidence.
Front Immunol
Li Z, Lei X, Guo X, He Q, Han Y, Zhang P, Du L, Qu B.
PMID: 42136663 [PubMed - indexed for MEDLINE]
The immune microenvironment of the central nervous system and neuromodulation: new perspectives in lung cancer brain metastases research.
Front Immunol
Yang X, Huo C, Tian J, Xiong Z, Yao J, Luo B.
PMID: 42136662 [PubMed - indexed for MEDLINE]
CT-based immune radiomic signature for prognosis and prediction of immunotherapy and anticancer drug response in NSCLC.
Front Immunol
Ma J, Guo K, Gao Y, Li T, Li F, Pang C, Geng Y, Guo J.
PMID: 42136648 [PubMed - indexed for MEDLINE]
PD-L1 expression is associated with inferior outcomes independent of EGFR subtype in advanced non-small cell lung cancer with uncommon EGFR mutations treated with first-line second-generation EGFR-tyrosine kinase inhibitors.
Cancer
Jin H, Wang Y, Zhang Y, Wu Y, Liu T, Xu J, Chu T, Zhong H, Yang H, Zhong R.
PMID: 42136330 [PubMed - indexed for MEDLINE]
Study on the anti-lung cancer effects of Gracillin from Reineckia carnea by targeting STC1.
BMC Cancer
Cui A, Tian Y, Chen H, Shi L, Zhu J, Wang B, Huang H, Li M, Liu H, Yang J.
PMID: 42135683 [PubMed - as supplied by publisher]
Investigating the impact of key algorithm parameters and patient-specific factors on the accuracy of CT ventilation imaging.
J Appl Clin Med Phys
Lim J, Kipritidis J, Booth JT, Keall PJ, Byrne HL.
PMID: 42135269 [PubMed - indexed for MEDLINE]
Morning versus afternoon administration of immune checkpoint inhibitors in metastatic non-small-cell lung cancer.
J Immunother Cancer
Gonzalez RT, Datta R, Rehmani S, Strohbehn GW, Ramnath N, Jalal S, Dykstra MP, Nieto J, Elliott D, Schipper MJ, Bryant AK.
PMID: 42134900 [PubMed - indexed for MEDLINE]
Multicenter Cohort Study of Original or Substitute Systemic Therapy With or Without Brain Radiotherapy for Extensive-Stage Small Cell Lung Cancer With Brain-Only Progression After First-Line Treatment.
J Clin Oncol
Lu S, Jia J, Ren K, Jia W, Sun Z, Zhao K, Cai X, Zhao L, Zhu H.
PMID: 42133905 [PubMed - as supplied by publisher]
Temporal Trends in Lung Cancer Cases Diagnosed at Early Stage.
JAMA Oncol
Henley SJ, Adam EE, Kava CM, Wu M.
PMID: 42133301 [PubMed - as supplied by publisher]
Optimal combination of heart and lung dose parameters in radiotherapy for locally advanced non-small cell lung carcinoma: a multicenter retrospective study.
J Radiat Res
Miyazaki T, Yasuda K, Taguchi H, Minatogawa H, Inoue T, Takashina R, Otsuka M, Nakazato K, Nishiyama N, Kobashi K, Otake I, Sakakibara-Konishi J, Oizumi S, Kikuchi H, Hashimoto T, Aoyama H.
PMID: 42132624 [PubMed - as supplied by publisher]
Harnessing the immune system in lung cancer: emerging role of the microbiome.
Expert Rev Clin Immunol
Roostaei G, Riahi T, Nikfar S, Abdollahi M.
PMID: 42132238 [PubMed - as supplied by publisher]
Artikel 1 - 20 / 159615
Seite 1 von 7981
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung